Usefulness of KL-6 for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients

Background: Krebs von den Lungen 6 (KL-6) is a novel biomarker for interstitial lung disease, and it reflects acute lung injury. We explored the usefulness of KL-6 to predict clinical outcomes in hospitalized coronavirus disease 2019 (COVID-19) patients. Methods: In a total of 48 hospitalized COVID-...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Mikyoung, Hur, Mina, Kim, Hanah, Lee, Chae Hoon, Lee, Jong Ho, Nam, Minjeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608840/
https://www.ncbi.nlm.nih.gov/pubmed/36295478
http://dx.doi.org/10.3390/medicina58101317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608840/
https://www.ncbi.nlm.nih.gov/pubmed/36295478
http://dx.doi.org/10.3390/medicina58101317

Ejemplares similares